Literature DB >> 1530608

Structure of the human heparin-binding growth factor gene pleiotrophin.

S Lai1, F Czubayko, A T Riegel, A Wellstein.   

Abstract

We report that the human gene coding for the heparin-binding growth factor pleiotrophin (PTN) spans more than 65 kb and contains at least 7 exons. Analysis of human genomic DNA fragments showed that the open reading frame (ORF) is located on 4 exons. The splice sites in the ORF coincide with the boundaries of functional domains in the human PTN protein and appear to be conserved in the mouse PTN and in the related family of midkine genes. The 5'- and the 3'-ends in the untranslated regions of the human PTN are distinct from those of other species and are highly homologous to the antisense cDNAs of heat shock protein 70 and of ribosomal protein L7 respectively. These two regions are located on separate exons and could play a role in the posttranscriptional regulation of human PTN gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530608     DOI: 10.1016/0006-291x(92)91312-e

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus.

Authors:  A M Schulte; S Lai; A Kurtz; F Czubayko; A T Riegel; A Wellstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 2.  Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.

Authors:  F Czubayko; A M Schulte; S C Missner; S S Hsieh; K J Colley; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 3.  The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.

Authors:  A T Riegel; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 4.  Growth factor targeted and conventional therapy of breast cancer.

Authors:  A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 5.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Chicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomas.

Authors:  Jin-Young Lee; Wooyoung Jeong; Whasun Lim; Jinyoung Kim; Fuller W Bazer; Jae Yong Han; Gwonhwa Song
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.